1. Home
  2. VS vs INTS Comparison

VS vs INTS Comparison

Compare VS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • INTS
  • Stock Information
  • Founded
  • VS 2013
  • INTS 2012
  • Country
  • VS United States
  • INTS United States
  • Employees
  • VS N/A
  • INTS N/A
  • Industry
  • VS EDP Services
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • INTS Health Care
  • Exchange
  • VS Nasdaq
  • INTS Nasdaq
  • Market Cap
  • VS 9.6M
  • INTS 10.9M
  • IPO Year
  • VS N/A
  • INTS 2023
  • Fundamental
  • Price
  • VS $2.08
  • INTS $0.23
  • Analyst Decision
  • VS Hold
  • INTS Strong Buy
  • Analyst Count
  • VS 1
  • INTS 4
  • Target Price
  • VS $2.00
  • INTS $4.50
  • AVG Volume (30 Days)
  • VS 315.5K
  • INTS 4.0M
  • Earning Date
  • VS 11-13-2025
  • INTS 11-12-2025
  • Dividend Yield
  • VS N/A
  • INTS N/A
  • EPS Growth
  • VS N/A
  • INTS N/A
  • EPS
  • VS N/A
  • INTS N/A
  • Revenue
  • VS $2,183,196.00
  • INTS N/A
  • Revenue This Year
  • VS $3,459.21
  • INTS N/A
  • Revenue Next Year
  • VS N/A
  • INTS N/A
  • P/E Ratio
  • VS N/A
  • INTS N/A
  • Revenue Growth
  • VS 1873.85
  • INTS N/A
  • 52 Week Low
  • VS $1.00
  • INTS $0.19
  • 52 Week High
  • VS $9.59
  • INTS $4.30
  • Technical
  • Relative Strength Index (RSI)
  • VS 49.67
  • INTS 32.86
  • Support Level
  • VS $1.80
  • INTS $0.27
  • Resistance Level
  • VS $2.02
  • INTS $0.30
  • Average True Range (ATR)
  • VS 0.09
  • INTS 0.02
  • MACD
  • VS 0.03
  • INTS -0.00
  • Stochastic Oscillator
  • VS 96.55
  • INTS 6.39

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: